FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

M Takiguchi

Research Profile

Chemicals & Drugs

Anatomy

Physiology

Phenomena

Protein Binding

Procedures

Flow Cytometry

Co-author Network

Publications

TOP 3
Satoshi Yamazaki; Nao Suzuki; Tsuneyoshi Saito; Yumiko Ishii; M Takiguchi; Hiromitsu Nakauchi; Nobukazu Watanabe
A rapid and efficient strategy to generate allele-specific anti-HLA monoclonal antibodies.
Yuichi Ando; Yoshifumi Beck; S Nakayama; A Asami; Y Nomura; Shinji Tomikawa; M Takiguchi
Induction of long-term heart graft survival by intrathymic injection of HLA class I peptide: a study with HLA class I transgenic mice model.
Yuichi Ando; Yoshifumi Beck; Shinji Tomikawa; Masazumi Eriguchi; T Muto; M Takiguchi
Cell-mediated graft rejection observed in two lines of human histocompatibility leukocyte antigen class I transgenic mice.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of M Takiguchi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Satoshi Yamazaki; Nao Suzuki; Tsuneyoshi Saito; Yumiko Ishii; M Takiguchi; Hiromitsu Nakauchi; Nobukazu Watanabe
A rapid and efficient strategy to generate allele-specific anti-HLA monoclonal antibodies.
Journal of immunological methods 2009;343(1):56-60.
2000: Yuichi Ando; Yoshifumi Beck; S Nakayama; A Asami; Y Nomura; Shinji Tomikawa; M Takiguchi
Induction of long-term heart graft survival by intrathymic injection of HLA class I peptide: a study with HLA class I transgenic mice model.
Transplantation proceedings 2000;32(7):2049-50.
1999: Yuichi Ando; Yoshifumi Beck; Shinji Tomikawa; Masazumi Eriguchi; T Muto; M Takiguchi
Cell-mediated graft rejection observed in two lines of human histocompatibility leukocyte antigen class I transgenic mice.
Transplantation 1999;68(6):904-8.
1999: A Kawana; H Tomiyama; M Takiguchi; Tatsuo Shioda; Tetsuya Nakamura; Aikichi Iwamoto
Accumulation of specific amino acid substitutions in HLA-B35-restricted human immunodeficiency virus type 1 cytotoxic T lymphocyte epitopes.
AIDS research and human retroviruses 1999;15(12):1099-107.
1998: Y Chujoh; Y Sobao; K Miwa; Y Kaneko; M Takiguchi
The role of anchor residues in the binding of peptides to HLA-A*1101 molecules.
Tissue antigens 1998;52(6):501-9.
1998: Yuichi Ando; Yoshifumi Beck; N Ichikawa; K Meigata; Y Nomura; Y Nishimura; Shinji Tomikawa; M Takiguchi
Induction of long-term heart graft survival in HLA class I transgenic mice by intrathymic injection of HLA class I peptides.
Transplantation proceedings 1998;30(7):3890-1.
1998: Y Ikeda-Moore; H Tomiyama; M Ibe; Shinichi Oka; K Miwa; Y Kaneko; M Takiguchi
Identification of a novel HLA-A24-restricted cytotoxic T-lymphocyte epitope derived from HIV-1 Gag protein.
AIDS (London, England) 1998;12(15):2073-4.
1998: N Yamada; T Nagatani; M Takiguchi
T cells expressing killer cell inhibitory receptors do not carry TCR for alloantigens.
Human immunology 1998;59(8):488-92.
1998: M Ibe; T Sakaguchi; Kiyoji Tanaka; S Saito; S Yokota; T Tanaka; K Shimotohno; Y Chujoh; Yasushi Shiratori; Masao Omata; K Miwa; M Takiguchi
Identification and characterization of a cytotoxic T cell epitope of hepatitis C virus presented by HLA-B*3501 in acute hepatitis.
The Journal of general virology 1998;79 ( Pt 7)():1735-44.
1998: H Nakajima; N Yamada; M Takiguchi
Fas-independent apoptosis of T cells via killer cell inhibitory receptors.
International immunology 1998;10(1):85-90.
1998: H Kubo; Y Ikeda-Moore; A Kikuchi; K Miwa; K Nokihara; Christian Schönbach; M Takiguchi
Residue 116 determines the C-terminal anchor residue of HLA-B*3501 and -B*5101 binding peptides but does not explain the general affinity difference.
Immunogenetics 1998;47(3):256-63.
1998: T Sakaguchi; Y Takamiya; M Edidin; K Nokihara; K Miwa; Christian Schönbach; M Takiguchi
Crucial role of N-terminal residue of binding peptides in recognition of the monoclonal antibody specific for the peptide-HLA-B5, -B35 complex.
Immunogenetics 1998;47(2):149-58.
1997: Y Ikeda-Moore; H Tomiyama; K Miwa; Shinichi Oka; Aikichi Iwamoto; Y Kaneko; M Takiguchi
Identification and characterization of multiple HLA-A24-restricted HIV-1 CTL epitopes: strong epitopes are derived from V regions of HIV-1.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(12):6242-52.
1997: T Sakaguchi; M Takiguchi
[Peptide binding motif for HLA class I and autoimmune disease].
Nihon rinsho. Japanese journal of clinical medicine 1997;55(6):1397-402.
1997: H Tomiyama; K Miwa; H Shiga; Y I Moore; Shinichi Oka; Aikichi Iwamoto; Y Kaneko; M Takiguchi
Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(10):5026-34.
1997: T Sakaguchi; M Ibe; K Miwa; S Yokota; Kiyoji Tanaka; Christian Schönbach; M Takiguchi
Predominant role of N-terminal residue of nonamer peptides in their binding to HLA-B* 5101 molecules.
Immunogenetics 1997;46(3):245-8.
1997: T Sakaguchi; M Ibe; K Miwa; Y Kaneko; S Yokota; Kiyoji Tanaka; M Takiguchi
Binding of 8-mer to 11-mer peptides carrying the anchor residues to slow assembling HLA class I molecules (HLA-B*5101).
Immunogenetics 1997;45(4):259-65.
1997: H Nakajima; Y I Moore; M Takiguchi
Functional expression of the NKB1 killer cell inhibitory receptors on agammadelta CTL clone.
Immunogenetics 1997;45(3):226-8.
1996: M Takiguchi
[Identification of T cell epitopes by reverse immunogenetics].
Nihon rinsho. Japanese journal of clinical medicine 1996;54(12):3379-88.
1996: Christian Schönbach; K Nokihara; C R Bangham; A Kariyone; S Karaki; H Shida; Kiyoshi Takatsu; K Egawa; K H Wiesmüller; M Takiguchi
Identification of HTLV-1-specific CTL directed against synthetic and naturally processed peptides in HLA-B*3501 transgenic mice.
Virology 1996;226(1):102-12.
1996: H Nakajima; M Takiguchi
Regulation of CTL recognition by receptors for HLA-DR molecules.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(6):2239-42.
1996: H Shiga; Tatsuo Shioda; H Tomiyama; Y Takamiya; Shinichi Oka; S Kimura; Y Yamaguchi; T Gojoubori; H G Rammensee; K Miwa; M Takiguchi
Identification of multiple HIV-1 cytotoxic T-cell epitopes presented by human leukocyte antigen B35 molecules.
AIDS (London, England) 1996;10(10):1075-83.
1996: Y Takamiya; T Sakaguchi; K Miwa; M Takiguchi
Role of HLA-B*5101 binding nonamer peptides in formation of the HLA-Bw4 public epitope.
International immunology 1996;8(7):1027-34.
1996: A Kikuchi; T Sakaguchi; K Miwa; Y Takamiya; H G Rammensee; Y Kaneko; M Takiguchi
Binding of nonamer peptides to three HLA-B51 molecules which differ by a single amino acid substitution in the A-pocket.
Immunogenetics 1996;43(5):268-76.
1996: Christian Schönbach; K Miwa; M Ibe; H Shiga; K Nokihara; M Takiguchi
Refined peptide HLA-B*3501 binding motif reveals differences in 9-mer to 11-mer peptide binding.
Immunogenetics 1996;45(2):121-9.
1996: M Ibe; Y I Moore; K Miwa; Y Kaneko; S Yokota; M Takiguchi
Role of strong anchor residues in the effective binding of 10-mer and 11-mer peptides to HLA-A*2402 molecules.
Immunogenetics 1996;44(4):233-41.
1995: H Nakajima; H Tomiyama; M Takiguchi
Inhibition of gamma delta T cell recognition by receptors for MHC class I molecules.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(9):4139-42.
1995: Christian Schönbach; M Ibe; H Shiga; Y Takamiya; K Miwa; K Nokihara; M Takiguchi
Fine tuning of peptide binding to HLA-B*3501 molecules by nonanchor residues.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(11):5951-8.
1995: H Tomiyama; Y Takamiya; Ann B Hill; V Cerundolo; A Kelly; K Egawa; J Trowsdale; M Takiguchi
Isolation of a human allo-peptide presented by HLA-B51 molecules.
International immunology 1995;7(6):905-9.
1994: A Ogawa; Katsushi Tokunaga; F Nakajima; A Kikuchi; S Karaki; Koichi Kashiwase; J Ge; K Hannestad; Takeo Juji; M Takiguchi
Identification of the gene encoding a novel HLA-B39 subtype. Two amino acid substitutions on the beta-sheet out of the peptide-binding floor form a novel serological epitope.
Human immunology 1994;41(4):241-7.
1994: M Takiguchi
[Structure of MHC molecules and binding peptides].
Nihon rinsho. Japanese journal of clinical medicine 1994;52(11):2817-23.
1994: M Takiguchi; G Kawaguchi; M Sekimata; M Hiraiwa; A Kariyone; Y Takamiya
The role of the conserved residue in pocket A and the polymorphic residue in pocket E of HLA-B*3501 in presentation of human minor histocompatibility peptides to T cells.
International immunology 1994;6(9):1345-52.
1994: S Nakayama; G Kawaguchi; S Karaki; Takeshi Nagao; H Uchida; Koichi Kashiwase; T Akaza; T Nasuno; M Takiguchi
Effect of single amino acid substitution at residue 167 of HLA-B51 on binding of antibodies and recognition of T cells.
Human immunology 1994;39(3):211-9.
1994: Y Takamiya; Christian Schönbach; K Nokihara; Mitsuko Yamaguchi; S Ferrone; K Kano; K Egawa; M Takiguchi
HLA-B*3501-peptide interactions: role of anchor residues of peptides in their binding to HLA-B*3501 molecules.
International immunology 1994;6(2):255-61.
1993: G Kawaguchi; S Nakayama; Takeshi Nagao; M Takiguchi
A single amino acid substitution at residue 167 forms a novel HLA-B51 subtype.
Tissue antigens 1993;42(1):39-41.
1993: M Sekimata; M Tanabe; A Sarai; J Yamamoto; A Kariyone; H Nakauchi; K Egawa; M Takiguchi
Different effects of substitutions at residues 224 and 228 of MHC class I on the recognition of CD8.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(10):4416-26.
1993: N Kato; A Kikuchi; K Kano; K Egawa; M Takiguchi
Molecular analysis of a novel HLA-A33 subtype associated with HLA-B44.
Tissue antigens 1993;41(4):211-3.
1993: G Kawaguchi; N Kato; Koichi Kashiwase; S Karaki; T Kohsaka; T Akaza; K Kano; M Takiguchi
Structural analysis of HLA-B40 epitopes.
Human immunology 1993;36(3):193-8.
1993: T Okazaki; C Nakanishi-Ito; N Seo; T Tanino; M Takiguchi; K Egawa
Recognition of the Qa-2k tumor antigen by T cell receptor gamma/delta of an immunopotentiator-induced tumoricidal T cell of mice.
Cancer immunology, immunotherapy : CII 1993;36(2):83-8.
1993: S Karaki; A Kariyone; N Kato; K Kano; Y Iwakura; M Takiguchi
HLA-B51 transgenic mice as recipients for production of polymorphic HLA-A, B-specific antibodies.
Immunogenetics 1993;37(2):139-42.
1993: N Kato; S Karaki; Koichi Kashiwase; C Müller; T Akaza; Takeo Juji; K Kano; M Takiguchi
Molecular analysis of HLA-B39 subtypes.
Immunogenetics 1993;37(3):212-6.
1992: N Kato; F Ward; K Kano; M Takiguchi
Conservation of genes encoding HLA-B5 and B35 cross-reactive group antigens in various races.
Human immunology 1992;35(4):253-5.
1992: S Karaki; M Tanabe; H Nakauchi; M Takiguchi
Beta-chain broadens range of CD8 recognition for MHC class I molecule.
Journal of immunology (Baltimore, Md. : 1950) 1992;149(5):1613-8.
1992: M Tanabe; M Sekimata; S Ferrone; M Takiguchi
Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I alpha 3 domain.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(10):3202-9.
1992: M Sekimata; P Griem; K Egawa; H G Rammensee; M Takiguchi
Isolation of human minor histocompatibility peptides.
International immunology 1992;4(2):301-4.
1992: M Tanabe; S Karaki; M Takiguchi; H Nakauchi
Antigen recognition by the T cell receptor is enhanced by CD8 alpha-chain binding to the alpha 3 domain of MHC class I molecules, not by signaling via the cytoplasmic domain of CD8 alpha.
International immunology 1992;4(2):147-52.
1992: M Hiraiwa; I Nishimura; N Kato; Takeshi Nagao; K Kano; M Takiguchi
Effect of the substitutions in the alpha helix and the beta sheet of HLA class I molecule on allorecognition of T cells specific for HLA-B51 and HLA-Bw53.
Human immunology 1992;33(2):82-8.
1991: M Hiraiwa; J Yamamoto; K Matsumoto; S Karaki; Takeshi Nagao; K Kano; M Takiguchi
T cell can recognize the allospecificities formed by the substitution of amino acids associated with HLA-Bw4/Bw6 public epitopes.
Human immunology 1991;32(1):41-5.
1991: Yoichiro Iwakura; M Tosu; E Yoshida; M Takiguchi; K Sato; I Kitajima; Kiyoshi Nishioka; K Yamamoto; T Takeda; M Hatanaka
Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I.
Science (New York, N.Y.) 1991;253(5023):1026-8.
1991: M Hiraiwa; M Takiguchi; K Kano
Allorecognition of HLA-B5 cross reactive group antigens by human CTL clones.
Transplantation proceedings 1991;23(1 Pt 1):449-50.
1991: J Yamamoto; M Hiraiwa; H Hayashi; M Tanabe; K Kano; M Takiguchi
Two amino acid substitutions at residues 63 and 67 between HLA-B51 and HLA-Bw52 form multiple epitopes recognized by allogeneic T cells.
Immunogenetics 1991;33(4):286-9.
1990: A Kariyone; M Tanabe; Takeo Juji; K Kano; M Takiguchi
Functional expression of HLA-C blank antigens on human blood lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(11):3714-8.
1990: M Tanabe; M Minami; K Kano; M Takiguchi
The allorecognition of H-2Kb-specific CD4-CD8- T cell hybridomas is influenced by the substitution at residue 256 of MHC class I molecules.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(6):1968-73.
1990: K Matsumoto; J Yamamoto; M Hiraiwa; K Kano; M Takiguchi
Discrimination of HLA-B5 crossreactive group antigens by human allospecific CTL clones.
Transplantation 1990;49(6):1164-7.
1990: M Sekimata; M Hiraiwa; M Andrien; E Dupont; S Karaki; J Yamamoto; K Kano; M Takiguchi
Allodeterminants and evolution of a novel HLA-B5 CREG antigen, HLA-B SNA.
Journal of immunology (Baltimore, Md. : 1950) 1990;144(8):3228-33.
1990: J Yamamoto; A Kariyone; Nachio Akiyama; K Kano; M Takiguchi
Presentation of human minor histocompatibility antigens by HLA-B35 and HLA-B38 molecules.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(7):2583-7.
1990: H Hayashi; T Ooba; S Nakayama; M Sekimata; K Kano; M Takiguchi
Allospecificities between HLA-Bw53 and HLA-B35 are generated by substitution of the residues associated with HLA-Bw4/Bw6 public epitopes.
Immunogenetics 1990;32(3):195-9.
1989: J Yamamoto; M Tanabe; M Minami; K Kano; M Takiguchi
Allo-class I-reactive CD4-CD8- T cell hybridomas recognize the conformational change of class I molecule resulting from the exchange of the alpha 3 domain.
European journal of immunology 1989;19(10):1861-5.
1989: M Takiguchi; I Nishimura; H Hayashi; S Karakl; A Kariyone; K Kano
The structure and expression of genes encoding serologically undetected HLA-C locus antigens.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(4):1372-8.
1989: M Tanabe; M Takiguchi; J Yamamoto; H Hayashi; K Kano
Analysis of xenoantigenicity of HLA class I molecules by a complete series of human-mouse hybrid genes.
Transplantation 1989;48(1):135-40.
1989: T Ooba; H Hayashi; S Karaki; M Tanabe; K Kano; M Takiguchi
The structure of HLA-B35 suggests that it is derived from HLA-Bw58 by two genetic mechanisms.
Immunogenetics 1989;30(2):76-80.
1989: M Sekimata; H Hayashi; S Nakayama; K Kano; M Takiguchi
Serological demonstration of HLA-Bw4/Bw6 epitopes on hybrid molecules between HLA-B35 and HLA-B51.
Immunogenetics 1989;30(3):229-31.
1988: A Kariyone; M Takiguchi; S Igarashi; K Kano
Ontogeny and function of B220+ L3T4+ T-cell subset of MRL/Mp-lpr/lpr mice.
Cellular immunology 1988;115(1):112-20.
1988: S Igarashi; M Takiguchi; A Kariyone; K Kano
Phenotypic and functional analyses on T-cell subsets in lymph nodes of MRL/Mp-lpr/lpr mice.
International archives of allergy and applied immunology 1988;86(3):249-55.